|
28
|
130
|
7fwxA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 |
|
32
|
134
|
7fzwA |
Crystal structure of human fabp4 in complex with 2-[[5-bromo-2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
129
|
7fyaA |
Crystal structure of apo human fabp1 - orthorhombic form |
|
31
|
134
|
7g0lA |
Crystal structure of human fabp4 in complex with 3-[(4-methyl-3-phenoxyphenyl)methyl]-1h-pyrazol-5-ol |
|
31
|
134
|
7fx5A |
Crystal structure of human fabp4 in complex with 5-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-6,6-difluoro-5,7-dihydro-4h-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-4-carboxylic acid |
|
32
|
134
|
7g07A |
Crystal structure of human fabp4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-5-carboxylic acid |
|
29
|
134
|
7g0uA |
Crystal structure of human fabp4 in complex with 5-[(3-chlorophenyl)methyl]-6-hydroxy-1-methyl-4-morpholin-4-ylpyrimidin-2-one |
|
31
|
132
|
7fzgA |
Crystal structure of apo mouse fabp4, c-centered orthorhombic form |
|
31
|
133
|
7fzlA |
Crystal structure of human fabp4 in complex with 3-(3-chlorophenyl)-4-prop-2-enyl-1h-1,2,4-triazole-5-thione |
|
34
|
134
|
7fwuA |
Crystal structure of human fabp4 in complex with 2-(fluoren-9-ylidenemethyl)-4-hydroxy-2,3-dihydropyran-6-one |
|
32
|
134
|
7g0rA |
Crystal structure of human fabp4 in complex with 4-methoxy-1,2-benzoxazol-3-amine |
|
32
|
133
|
7g14A |
Crystal structure of human fabp4 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
31
|
134
|
7fx6A |
Crystal structure of human fabp4 in complex with n,n-diethyl-4-pyridin-4-yl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-2-amine |
|
33
|
133
|
7fx8A |
Crystal structure of human fabp4 in complex with 4-(2-methylpropyl)-2-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
34
|
133
|
7fwoA |
Crystal structure of human fabp4 in complex with 2-cyclohexyl-6-hydroxy-1-benzofuran-3-one |
|
33
|
135
|
7fwqA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 6-chloro-4-(2-chlorophenoxy)-2-methylquinoline-3-carboxylic acid |
|
32
|
134
|
7fwwA |
Crystal structure of human fabp4 in complex with (3-bromophenyl)-[(2z)-2-phenylimino-1,3-thiazepan-3-yl]methanone |
|
32
|
135
|
7fw4A |
Crystal structure of human fabp4 soaked with glycerol |
|
32
|
133
|
7g1kA |
Crystal structure of human fabp4 in complex with 4-(4-fluorophenyl)sulfanyl-6-methyl-2-phenylpyrimidine-5-carboxylic acid |
|
31
|
133
|
7fzdA |
Crystal structure of human fabp4 in complex with 3-(4-chlorophenyl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d][1,2]oxazole-5-carboxylic acid |
|
31
|
133
|
7g1eA |
Crystal structure of human fabp4 in complex with 3-[(2-phenylphenoxy)methyl]benzoic acid |
|
33
|
134
|
7fxjA |
Crystal structure of human fabp4 in complex with 1-[(4-chlorophenyl)methyl]-3,4-dihydroxy-2h-pyrrol-5-one |
|
33
|
134
|
7fwaA |
Crystal structure of human fabp4 in complex with 5-[(4-chloroanilino)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
31
|
134
|
7fz6A |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-(phenoxymethyl)cyclohexane-1-carboxylic acid |
|
31
|
133
|
7fvyA |
Crystal structure of human fabp4 in complex with 2-[(3-chlorophenyl)methyl]-1,3-thiazole-4-carboxylic acid |
|
36
|
134
|
7g0aA |
Crystal structure of human fabp4 in complex with 5-(6-chloro-4-phenyl-2-piperidin-1-ylquinolin-3-yl)-3h-1,3,4-oxadiazol-2-one |
|
32
|
133
|
7fw0A |
Crystal structure of human fabp4 in complex with 3-methyl-2-(2,4,5-trichlorophenyl)sulfanylbutanoic acid |
|
32
|
135
|
7fzvA |
Crystal structure of human fabp4 in complex with 1-[(2,4-dichlorophenyl)methyl]-4-hydroxy-3-[(e)-3-phenylprop-2-enyl]pyridin-2-one |
|
32
|
133
|
7fw3A |
Crystal structure of human fabp4 in complex with 7-(4-chlorophenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid |
|
32
|
134
|
7g0sA |
Crystal structure of human fabp4 in complex with 2,3-bis(phenylmethoxy)benzoic acid |
|
30
|
134
|
7g1uA |
Crystal structure of human fabp4 in complex with 2-[[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
134
|
7fysA |
Crystal structure of human fabp4 in complex with 7-(4-methoxyphenyl)-1,8-dithia-3-azaspiro[4.5]dec-6-ene-2,4-dione |
|
32
|
131
|
7fytA |
Crystal structure of human fabp4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
33
|
133
|
7fycA |
Crystal structure of human fabp4 in complex with (2r)-1-[(2-phenylphenyl)carbamoyl]pyrrolidine-2-carboxylic acid |
|
33
|
134
|
7g17A |
Crystal structure of human fabp4 in complex with 2-(1h-indol-7-yloxymethyl)-1,3-thiazole-4-carboxylic acid |
|
35
|
134
|
7fy0A |
Crystal structure of human fabp5 in complex with (2r)-1-[(3,5-dichloro-2-phenylphenyl)carbamoyl]pyrrolidine-2-carboxylic acid |
|
34
|
135
|
7fz0A |
Crystal structure of human fabp4 in complex with 2-tert-butyl-6-ethyl-4,5-diphenyl-3-(1h-tetrazol-5-yl)pyridine |
|
31
|
133
|
7fzkA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with myristate |
|
31
|
133
|
7fweA |
Crystal structure of human fabp4 in complex with 3-(4-chlorophenyl)sulfanylbutanoic acid |
|
31
|
133
|
7g1lA |
Crystal structure of human fabp4 in complex with 6-(1,3-benzodioxol-5-ylmethyl)-3-sulfanyl-1,2,4-triazin-5-ol |
|
33
|
134
|
7g1nA |
Crystal structure of human fabp4 in complex with rac-(1r,2r)-2-[[3-(3-methyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]cyclohexane-1-carboxylic acid |
|
34
|
133
|
7fwrA |
Crystal structure of human fabp4 in complex with 3-[(3,4-dichlorophenyl)methylsulfanyl]-1,2,4-triazin-5-ol |
|
32
|
133
|
7g1vA |
Crystal structure of human fabp4 in complex with 3-[(2-sulfanylphenyl)carbamoyl]bicyclo[2.2.1]heptane-2-carboxylic acid |
|
30
|
134
|
7fzrA |
Crystal structure of human fabp4 in complex with 4-hydroxy-6-(2-naphthalen-1-ylethyl)pyran-2-one |
|
27
|
130
|
7fwfA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 5-cyclohexyl-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
28
|
130
|
7fzuA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-(indole-1-carbonylamino)benzoic acid |
|
31
|
135
|
7fwmA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 1-[(4-chloro-2-phenylphenyl)methyl]-4-hydroxypyridin-2-one |
|
31
|
134
|
7fz8A |
Crystal structure of human fabp4 in complex with thieno[2,3-d]pyrimidine-2,4-diamine |
|
30
|
134
|
7fwzA |
Crystal structure of human fabp4 in complex with 4-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-4h-cyclohepta[c]pyrazol-1-yl]butanoic acid |
|
29
|
130
|
7fx2A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-[[6,6-difluoro-3-(4-methyl-1,3-thiazol-2-yl)-5,7-dihydro-4h-1-benzothiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
